*These authors contributed equally to this work.
Version of Record online: 27 MAY 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 58, Issue 1, pages 388–396, July 2013
How to Cite
Chen, M., Borlak, J. and Tong, W. (2013), High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology, 58: 388–396. doi: 10.1002/hep.26208
Potential conflict of interest: Nothing to report.
Supported by the German Federal Ministry for Education and Research as part of the Virtual Liver Network initiative (grant 031 6154 to J.B.). J.B. is a recipient of an ORISE Stipend of the US Food and Drug Administration.
The views presented in this article do not necessarily reflect those of the US Food and Drug Administration.
- Issue online: 24 JUN 2013
- Version of Record online: 27 MAY 2013
- Accepted manuscript online: 19 DEC 2012 11:42AM EST
- Manuscript Accepted: 11 DEC 2012
- Manuscript Received: 24 AUG 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26208_sm_SuppFig1.tif||769K||Supporting Information Figure 1.|
|HEP_26208_sm_SuppFig2.tif||779K||Supporting Information Figure 2.|
|HEP_26208_sm_SuppFig3.tif||792K||Supporting Information Figure 3.|
|HEP_26208_sm_SuppFig4.tif||767K||Supporting Information Figure 4.|
|HEP_26208_sm_SuppFig5.tif||968K||Supporting Information Figure 5.|
|HEP_26208_sm_SuppTab1-5.doc||514K||Supporting Information Tables 1 to 5.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.